Articles about Biological E

Biological E is a long-standing Indian pharmaceutical company that was founded during the Swadeshi Movement in the country. The company was founded and led by Dr. D.K.V. Raju. It commenced operations in 1953 as a company making biological products such as liver extracts and anticoagulants. In 1962, the company transitioned to manufacturing DPT vaccines at a large scale so diseases could be prevented instead of treated. The wing responsible for this is called the Vaccines and Biologics division. When the Coronavirus pandemic gripped the world, this Hyderabad-based firm announced that it is developing a vaccine that could be 90 percent effective against the COVID-19 disease. The company’s COVID-19 vaccine called Corbevax entered the third stage of trials. Despite pending authorization, the Indian government paid Biological E a sum of Rs. 1,500 crore for 30 crore vaccine doses, enough to inoculate 15 Crore citizens. Additionally, the Corbevax jab is expected to be one of the cheapest ones on offer, costing just Rs.. 250 for both doses.

India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon

04 May 2022

India
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon

India is set to begin the phase-2 trials of the world's first one-shot pneumococcal vaccine for adults soon.

35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab

15 Sep 2021

India
35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab

Around 35 lakh doses of the COVID-19 vaccine developed by United States pharma giant Johnson & Johnson have reportedly reached the apex vaccine testing laboratory in Kasauli, Himachal Pradesh.

Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October

09 Sep 2021

India
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October

The one-dose COVID-19 vaccine developed by American pharma giant Johnson & Johnson and manufactured by the company's local partner, Hyderabad-based Biological E, is likely to be available in India by October, reported News18.

Phase 2/3 trials of Corbevax on 5-18 age group permitted

02 Sep 2021

India
Phase 2/3 trials of Corbevax on 5-18 age group permitted

The Drugs Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its "Made in India" COVID-19 vaccine, Corbevax, on children aged between 5 and 18 years with certain conditions, sources said.

How Biological E's coronavirus vaccine could be a potential gamechanger

17 Jun 2021

India
How Biological E's coronavirus vaccine could be a potential gamechanger

A made-in-India coronavirus vaccine being developed by the Hyderabad-based firm Biological E is expected to be up to 90% effective against COVID-19, an expert from a government advisory panel said.

India's neighbors train experts for clinical trials of COVID-19 vaccine

17 Dec 2020

India
India's neighbors train experts for clinical trials of COVID-19 vaccine

India's friendly neighboring nations trained over 100 experts to strengthen capacities in their countries for facilitating phase-3 clinical trials of the Indian COVID-19 vaccine, a senior official of the Department of Biotechnology said.

Modi to chair all-party meet to review COVID-19 situation Friday

30 Nov 2020

India
Modi to chair all-party meet to review COVID-19 situation Friday

Prime Minister Narendra Modi is set to chair an all-party meeting this Friday to review the COVID-19 situation in India, according to reports.

Can deliver coronavirus vaccine in a few months: Health Minister

19 Nov 2020

India
Can deliver coronavirus vaccine in a few months: Health Minister

India's Health Minister Dr. Harsh Vardhan said today that deliveries of coronavirus vaccine will happen within a few months, adding that the country's scientists are way ahead in terms of research.

India relying on five coronavirus vaccines to control pandemic

18 Nov 2020

India
India relying on five coronavirus vaccines to control pandemic

With heartening news of the coronavirus vaccine coming from different parts of the world, the Indian government is trying to understand which one would be the most feasible for the country.

India to play crucial role in COVID-19 vaccine process

20 Oct 2020

Technology
India to play crucial role in COVID-19 vaccine process

As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.

NewsBytes Briefing: US Senate subpoenas CEOs of Google, Facebook, Twitter

02 Oct 2020

Technology
NewsBytes Briefing: US Senate subpoenas CEOs of Google, Facebook, Twitter

Last night, the US Senate Commerce Committee voted unanimously to issue subpoenas to the CEOs of Facebook, Google, and Twitter.

Indian government starts talks to procure COVID-19 vaccine: Details here

18 Aug 2020

India
Indian government starts talks to procure COVID-19 vaccine: Details here

Amid surging COVID-19 cases and questions over the peak for India, the government has started working towards procuring a vaccine.

NewsBytes Briefing: Fortnite removed from app stores, and more

14 Aug 2020

Technology
NewsBytes Briefing: Fortnite removed from app stores, and more

In the updates since last night, Fortnite made major headlines.

COVAXIN will cost less than water bottle: Bharat Biotech MD

04 Aug 2020

India
COVAXIN will cost less than water bottle: Bharat Biotech MD

Ever since companies started developing vaccines for COVID-19, one big question has been on everyone's mind: how much the final, approved shot would cost to the public?